BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2452751)

  • 1. Thermodynamic analysis of antagonist and agonist interactions with dopamine receptors.
    Duarte EP; Oliveira CR; Carvalho AP
    Eur J Pharmacol; 1988 Mar; 147(2):227-39. PubMed ID: 2452751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors.
    Kilpatrick GJ; el Tayar N; Van de Waterbeemd H; Jenner P; Testa B; Marsden CD
    Mol Pharmacol; 1986 Sep; 30(3):226-34. PubMed ID: 2943980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple receptors for brain dopamine.
    Titeler M; Weinreich P; Sinclair D; Seeman P
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1153-6. PubMed ID: 418405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of [125I]-N-(p-aminophenethyl)spiroperidol to the D-2 dopamine receptor in the neurointermediate lobe of the rat pituitary gland: a thermodynamic study.
    Agui T; Amlaiky N; Caron MG; Kebabian JW
    Mol Pharmacol; 1988 Feb; 33(2):163-9. PubMed ID: 2963208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR; Molinoff PB
    Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partition coefficients of dopamine antagonists in brain membranes and liposomes.
    Oliveira CR; Lima MC; Carvalho CA; Leysen JE; Carvalho AP
    Biochem Pharmacol; 1989 Jul; 38(13):2113-20. PubMed ID: 2735949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.
    Lehmann J; Briley M; Langer SZ
    Eur J Pharmacol; 1983 Mar; 88(1):11-26. PubMed ID: 6133762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment.
    MacKenzie RG; Zigmond MJ
    J Neurochem; 1984 Nov; 43(5):1310-8. PubMed ID: 6208330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
    Hamblin MW; Leff SE; Creese I
    Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors.
    Contreras ML; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1986 Apr; 237(1):154-64. PubMed ID: 2870174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
    Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ
    Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide.
    Wreggett KA; Seeman P
    Mol Pharmacol; 1984 Jan; 25(1):10-7. PubMed ID: 6231467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immuno-photoaffinity labeling of the D2-dopamine receptor.
    Kanety H; Fuchs S
    Biochem Biophys Res Commun; 1988 Sep; 155(2):930-6. PubMed ID: 2458727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):52-6. PubMed ID: 7132962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species variation in dopamine receptor binding.
    Creese I; Stewart K; Snyder SH
    Eur J Pharmacol; 1979 Nov; 60(1):55-66. PubMed ID: 520417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiparkinsonian drug doses and neuroleptic receptors.
    Titeler M; Seeman P
    Experientia; 1978 Nov; 34(11):1490-2. PubMed ID: 720482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
    Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptors in rat brain regions. Optimal conditions for 3H-agonist binding, pH dependency and lack of inhibition by ascorbic acid.
    Bacopoulos NG
    Biochem Pharmacol; 1982 Oct; 31(19):3085-91. PubMed ID: 7150335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptors in the developing sheep kidney.
    Felder RA; Nakamura KT; Robillard JE; Kanadjian M; Jose PA
    Pediatr Nephrol; 1988 Jan; 2(1):156-62. PubMed ID: 3152990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.